Procaps Group Appoints Patricio Vargas as Global Chief Financial Officer to Support Global Expansion
Procaps Group has appointed Patricio Vargas as the new global Chief Financial Officer. With 25 years of public company finance experience, Vargas previously served as Finance VP at Empresas CMPC S.A. He has significant expertise in capital markets and business development. Vargas's appointment is seen as critical to Procaps’ ongoing global expansion and transition to a standalone public company on NASDAQ by the end of September. The company expects substantial cash proceeds to facilitate growth initiatives.
- Patricio Vargas brings 25 years of public company finance experience, enhancing the management team.
- His appointment aligns with Procaps' strategy for international growth and transition to a standalone public company on NASDAQ.
- The company anticipates approximately $236.9 million in cash proceeds to fund growth initiatives.
- Concerns may arise regarding continuity and experience gaps following the transition from previous CFO Sergio Mantilla.
Procaps Group, a leading integrated international healthcare and pharmaceutical company, has appointed Patricio Vargas as global Chief Financial Officer.
Mr. Vargas has 25 years of public company finance experience with proven capabilities in global financial management, business development and global capital markets. He joins Procaps after serving as Finance Vice President & Treasurer at Empresas CMPC S.A. (CMPC.CL), a pulp and paper company with more than
Previously, he was Chief Executive Officer at international food processor Agrofoods Central Valley Chile S.A. Prior to that, Mr. Vargas was the CFO of CFR Pharmaceuticals S.A. (“CFR”), and worked directly with then CEO, Alejandro Weinstein, who is currently both a shareholder of Procaps Group and is expected to be the Chairman of its M&A committee. Mr. Vargas previously worked with Mr. Weinstein to lead CFR’s initial public offering in 2011, as well as on over
“As Procaps Group continues to grow its operations worldwide, it is critical that we continue to globalize our executive management leadership,” said Ruben Minski, Procaps Founder, Chairman and Chief Executive Officer. “Patricio will add to the successful team that has been led by Sergio Mantilla, who has been extremely instrumental in preparing our company for the public markets. Patricio brings a dedicated work ethic as well as proven and concentrated expertise leading multibillion-dollar organizations with exponential growth both financially and geographically. His capital markets knowledge and financial skill set will be incredibly valuable with our expected upcoming evolution to a standalone public company on the Nasdaq, which is expected to occur by the end of September. Patricio adds to our recent hires of top senior management to our organization, with Camilo Camacho joining us as President in April of this year.
“We believe Patricio’s experience will be instrumental to our internationalization strategy and to help accelerate our growth, both organically and inorganically, into both existing and new markets. Patricio is set to start in his new role towards the end of September. We look forward to introducing Patricio to our investors and shareholders at our upcoming analyst day call on August 19th,” concluded Minski.
Mr. Vargas added, “I am thrilled to be joining Procaps Group, which I believe is uniquely positioned to continue its growth trajectory and efforts towards consolidation in the region. I am excited to be part of the company as it transitions into a public company, and I look forward to working with Ruben, Camilo, Sergio and the rest of the organization to help execute on the company’s plans and global growth objectives moving forward.”
Procaps Group Virtual Investor and Analyst Day - Thursday, August 19, 2021 at 10:00 a.m. Eastern Time
Procaps Group Chief Executive Officer Ruben Minski and other members of the senior management team will host the conference call. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of Procaps’ website here. This event will also include a question-and-answer period following management’s prepared remarks designed for both sell-side research analysts and institutional investors.
To access the call, please use the following information:
Date: |
Thursday, August 19, 2021 |
Time: |
10:00 a.m. EDT, 7:00 a.m. PDT |
Toll Free dial-in number: |
1-877-407-0789 |
Toll/International dial-in number: |
1-201-689-8562 |
Conference ID: |
13722118 |
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have difficulty connecting with the conference call, please contact MZ Group at +1 (949) 491-8235.
The conference call will be broadcast live and available for replay at http://public.viavid.com/index.php?id=146107 and via the investor relations section of Procaps’ website here.
A telephone replay will be available approximately two hours after the call until September 16, 2021, accessible by dialing 1-844-512-2921 from the U.S., or 1-412-317-6671 from international locations, and entering replay pin number: 13722118.
Expected Milestones to Completion of Business Combination Include:
- Second quarter 2021 financial results – Thursday, August 12, 2021
- Virtual investor and analyst day – Thursday, August 19, 2021
- Shareholder vote of Union Acquisition Corp. II (NASDAQ: LATN) – expected to take place in September 2021
- Closing of the business combination and listing on Nasdaq Capital Market under new ticker symbol “PROC” – approximately at the end of September 2021.
About the Proposed Business Combination with Union Acquisition Corp. II
Completion of the business combination, which is expected to close in the third quarter of 2021, is subject to approval by LATN shareholders and other customary closing conditions, including the Registration Statement being declared effective by the SEC. The combined company will be led by Ruben Minski, Procaps Group Founder, Chairman & CEO. Upon closing of the business combination (assuming none of the LATN shareholders redeem any of their LATN ordinary shares in connection with the approval of the business combination and including the redemption of certain shares held by IFC), existing Procaps Group shareholders are expected to hold approximately
Institutional investors have committed to an upsized private investment in public equity (“PIPE”) of
While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Procaps Group’s business and operations, proposed business combination with Union Acquisition Corp. II and the proposals to be considered by the LATN shareholders.
Additional information about the transaction including the Registration Statement on Form F-4 can be viewed here: https://investor.procapsgroup.com.
About Procaps Group
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in Latin America and, as of December 31, 2020, had more than 4,700 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions. For more information, visit www.procapsgroup.com or Procaps Group’s investor relations website investor.procapsgroup.com, which will also contain a link to the Registration Statement. The Registration Statement includes audited consolidated financial statements of Procaps Group as of and for the fiscal years ended December 31, 2020 and 2019.
About Union Acquisition Corp. II.
Union Acquisition Corp. II, led by Kyle Bransfield, is a Cayman Islands exempted company incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. For more information, please click here.
Important Information About the Merger and Where to Find It
In connection with the proposed business combination, Procaps Group, S.A. (“Holdco”), a subsidiary of Crynssen Pharma Group Limited (“Procaps Group”) that will be become the holding company of LATN and Procaps Group as of the closing of the proposed business combination, filed a Registration Statement on Form F-4 (the “Form F-4”) with the U.S. Securities and Exchange Commission (the “SEC”) that includes a proxy statement of LATN that also constitutes a prospectus of Holdco. LATN, Procaps Group and Holdco urge investors, stockholders and other interested persons to read the Form F-4, including the preliminary proxy statement/prospectus and amendments thereto and the definitive proxy statement/prospectus and documents incorporated by reference therein, as well as other documents filed with the SEC in connection with the proposed transaction, as these materials will contain important information about Procaps Group, Holdco, LATN and the proposed business combination transaction. After the Registration Statement is declared effective, the definitive proxy statement/prospectus included in the Registration Statement will be mailed to shareholders of LATN as of a record date to be established for voting on the proposed business combination. Once available, shareholders will also be able to obtain a copy of the Form F-4, including the proxy statement/prospectus, and other documents filed with the SEC without charge, by directing a request to: BTG Pactual US Capital, LLC, Attention: Prospectus Department, Email: OL-BTGPactual-ProspectusDepartment@btgpactual.com. The preliminary and definitive proxy statement/prospectus included in the registration statement, once available, can also be obtained, without charge, at the SEC’s website (www.sec.gov).
Participants in the Solicitation
LATN and Procaps Group and their respective directors and executive officers may be considered participants in the solicitation of proxies with respect to the proposed business combination described in this press release under the rules of the SEC. Information about the directors and executive officers of LATN is set forth in LATN’s final prospectus filed with the SEC pursuant to Rule 424(b) of the Securities Act of 1933, as amended (the “Securities Act”) on October 17, 2019, and is available free of charge at the SEC’s website at www.sec.gov or by directing a request to: Union Acquisition Corp. II, 1425 Brickell Ave., #57B, Miami, FL 33131. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the LATN shareholders in connection with the proposed business combination will be set forth in the Registration Statement filed with the SEC. These documents can be obtained free of charge from the sources indicated above.
Forward-Looking Statements
This press release contains “forward-looking statements.” Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends that are not statements of historical matters. Such forward-looking statements include the expected gross cash proceeds from the Procaps Group business combination and its effects on expansion; expectations relating to capacity expansion, plant improvements, working capital investments, e-health platform and R&D expenses; expectations related to potential M&A acquisitions; the closing of the business combination transaction; and expectations relating to Procaps Group’s ability to invest in growth through organic and inorganic growth. Such forward-looking statements with respect to the businesses of LATN, Procaps Group, or Holdco, prior to or following the completion of any proposed business combination, are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements in this press release include, but are not limited to: (1) the inability to complete the transactions contemplated by the proposed business combination; (2) the inability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition, and the ability of the combined business to grow and manage growth profitably; (3) the inability to successfully retain or recruits officers, key employees, or directors following the proposed business combination; (4) effects on LATN’s public securities’ liquidity and trading; (5) the market’s reaction to the proposed business combination; (6) the lack of a market for LATN’s securities; (7) LATN’s and Procaps Group’s financial performance following the proposed business combination; (8) costs related to the proposed business combination; (9) changes in applicable laws or regulations; (10) the possibility that LATN or Procaps Group may be adversely affected by other economic, business, and/or competitive factors; and (11) other risks and uncertainties indicated from time to time in documents filed or to be filed with the SEC by LATN. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, the ability to complete the business combination due to the failure to obtain approval from LATN shareholders or satisfy other closing conditions in the business combination agreement, the occurrence of any event that could give rise to the termination of the business combination agreement, the ability to recognize the anticipated benefits of the business combination, the outcome of any legal proceedings that may be instituted against LATN or Procaps Group following announcement of the proposed business combination and related transactions, the impact of COVID-19 on Procaps Group’s business and/or the ability of the parties to complete the business combination, the ability to obtain or maintain the listing LATN’s ordinary shares on Nasdaq following the proposed business combination, costs related to the proposed business combination, changes in applicable laws or regulations, the possibility that LATN or Procaps Group may be adversely affected by other economic, business, and/or competitive factors, and other risks and uncertainties, including those to be included under the header “Risk Factors” in the Form F-4 to be filed with the SEC and those included under the header “Risk Factors” in the final prospectus of LATN related to its initial public offering, as well as LATN’s other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.
Non-Solicitation
This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed business combination and shall not constitute an offer to sell or a solicitation of an offer to buy any securities nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005391/en/
FAQ
Who is the new Chief Financial Officer of Procaps Group?
What experience does Patricio Vargas bring to Procaps Group?
When is Procaps Group expected to transition to NASDAQ?
What financial support does Procaps Group expect after the business combination?
What are the upcoming milestones for Procaps Group?
